CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...